What is the evidence for treating lung cancer with chemotherapy and immunotherapy for a second time?
Abstract
Chemotherapy combined with immunotherapy for second-line treatment in lung cancer shows varied efficacy, with some combinations offering survival benefits, but generally with increased adverse events and limited comprehensive data.
Fields of Study & Subjects
Cancer Immunotherapy and Biomarkers
Lung Cancer Research Studies
Immunotherapy and Immune Responses
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 7 January 2026